Research Article: Effects of different therapy regimens to increase final adult height in males at advanced bone age with idiopathic short stature
Abstract:
This retrospective study explored the effect on adult height of a combination of recombinant human growth hormone (rhGH) and aromatase inhibitors (AIs), or rhGH and a gonadotropin-releasing hormone analog (GnRHa), and compared their effects with rhGH alone in males at advanced bone age with idiopathic short stature (ISS).
Introduction:
Recombinant human growth hormone (rhGH) therapy is the most effective treatment for idiopathic short stature (ISS) in children [1]. When given to prepubertal children, rhGH can successfully increase the growth velocity and adult height. However, due to early puberty onset and (or) delayed initial consultation, some adolescent children with ISS experience accelerated linear bone growth at the time of treatment [2]. It is generally agreed that an advanced stage of bone age in pubescent boys limits the application…
Read more